menu
    • menu

    Company profile for Tonix Pharmaceuticals Holding Corp

    NEW Drugs in Dev: 20
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Tonix is a research and development company that is focused on identifying promising new product candidates and advancing them through clinical development toward regulatory approval. Tonix is currently focused on discovering and developing pharmaceutical products to treat serious neuropsychiatric conditions and biological products to improve biodefense through potential medical counter-measures.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Tonix Pharmaceuticals Holding CorpUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    509 Madison Avenue Suite 306 New York, NY 10022
    Telephone
    Telephone
    (212) 980-9155
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.tonixpharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    IMCAS World Congress

    IMCAS World Congress

    Not Confirmed

    envelop Contact Supplier

    IMCAS World Congress

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tonix Pharma: Resilient Tonmya Data at 2026 Pain Conference
    Tonix Pharma: Resilient Tonmya Data at 2026 Pain Conference

    30 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/30/3229442/28908/en/Tonix-Pharmaceuticals-Presented-Phase-3-RESILIENT-Data-on-TONMYA-Cyclobenzaprine-HCl-Sublingual-Tablets-at-the-2026-Non-Opioid-Pain-Therapeutics-Summit.html

    GLOBENEWSWIRE
    30 Jan 2026
    Share Share
    Tonix Pharma To Present At 2 Investor Conferences In Jan 2026
    Tonix Pharma To Present At 2 Investor Conferences In Jan 2026

    06 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/06/3213458/28908/en/Tonix-Pharmaceuticals-to-Present-at-Two-Investor-Conferences-in-January-2026.html

    GLOBENEWSWIRE
    06 Jan 2026
    Share Share
    Tonix Pharma Prices $20M Registered Direct Offering
    Tonix Pharma Prices $20M Registered Direct Offering

    29 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/29/3210880/28908/en/Tonix-Pharmaceuticals-Announces-Pricing-of-20-0-Million-Registered-Direct-Offering.html

    GLOBENEWSWIRE
    29 Dec 2025
    Share Share
    Tonix Pharma Reveals Phase 2/3-Ready Long-Acting Antibody
    Tonix Pharma Reveals Phase 2/3-Ready Long-Acting Antibody

    29 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/29/3210878/28908/en/Tonix-Pharmaceuticals-Announces-Program-Updates-on-Phase-2-3-Ready-Long-Acting-Monoclonal-Antibody-mAb-Designed-for-Seasonal-Prevention-of-Lyme-Disease-TNX-4800.html

    GLOBENEWSWIRE
    29 Dec 2025
    Share Share
    Tonix Pharma Licenses TNX-4900, For Chronic Neuropathic Pain
    Tonix Pharma Licenses TNX-4900, For Chronic Neuropathic Pain

    16 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/16/3206086/28908/en/Tonix-Pharmaceuticals-Announces-Licensing-TNX-4900-a-Selective-Sigma-1-Receptor-Antagonist-for-Chronic-Neuropathic-Pain-from-Rutgers-University.html

    GLOBENEWSWIRE
    16 Dec 2025
    Share Share
    Tonix Pharmaceuticals Appoints Irina Ishak As General Counsel
    Tonix Pharmaceuticals Appoints Irina Ishak As General Counsel

    09 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/09/3202208/28908/en/Tonix-Pharmaceuticals-Appoints-Irina-Ishak-as-General-Counsel.html

    GLOBENEWSWIRE
    09 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search